Chemical Structure : IQS-019 mesylate
Catalog No.: PC-60404Not For Human Use, Lab Use Only.
IQS-019 mesylate is a potent inhibitor of most upstream tyrosine kinases in BCR signaling pathway, inhibits BCR kinases Lyn, Syk and Btk with IC50 of 0.15 uM, 1.6 uM and 2.1 uM, respectively.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IQS-019 mesylate is a potent inhibitor of most upstream tyrosine kinases in BCR signaling pathway, inhibits BCR kinases Lyn, Syk and Btk with IC50 of 0.15 uM, 1.6 uM and 2.1 uM, respectively.
IQS-019 mesylate inhibits at least 20% of the kinase activity at 0.1 uM) and an almost complete kinase inactivation at the 10 uM in a set of 17 TK/TKLs.
IQS-019 mesylate impaires cell proliferation, reduces CXCL12-dependent cell migration, and induces caspase-dependent apoptosis.
IQS-019 mesylate shows improved efficacy in vitro and in vivo compared to ibrutinib.
M.Wt | 606.523 | |
Formula | C26H29Cl2N7O4S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Balsas P, et al. J Hematol Oncol. 2017 Mar 31;10(1):80.
2. Puig de la Bellacasa R, et al. Eur J Med Chem. 2014 Oct 30;86:664-75.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright